 TUSTIN, Calif., June 22, 2022 GLOBE NEWSWIRE -- Avid Bioservices, Inc. NASDAQ:CDMO, a dedicated biologics contract development and manufacturing organization CDMO working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced that it will report financial results for the quarter and fiscal year ended April 30, 2022 on June 29, 2022 after market close and will host a conference call and webcast at 1:30 PM Pacific Time 4:30 PM Eastern Time. Members of Avids senior management will discuss financial results for the quarter and FY ended April 30, 2022 and review recent corporate developments. 